| 发明名称 |
LAMIVUDINE CRYSTALLINE SALTS |
| 摘要 |
The present disclosure relates to novel crystalline salt forms of lamivudine, methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of viruses such as Human Immunodeficiency Virus (HIV) infection. |
| 申请公布号 |
WO2014124092(A3) |
申请公布日期 |
2014.10.23 |
| 申请号 |
WO2014US15024 |
申请日期 |
2014.02.06 |
| 申请人 |
TOBIRA THERAPEUTICS, INC. |
发明人 |
DALZIEL, SEAN MARK;MENNING, MARK MICHAEL |
| 分类号 |
C07D411/04;A61K31/506;A61K31/513;A61P31/12;A61P31/18 |
主分类号 |
C07D411/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
